Together with the results of p53 and MDM2 analysis, these findings indicated the involvement of the p16INK4A and p14ARF tumor suppressor pathways, which resulted in cell cycle deregulation in malignant rhabdoid tumors [41]. The gene discussed is CDKN2A; the disease is rhabdoid tumor.